PremiumThe FlyLongboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings Largest borrow rate increases among liquid names Largest borrow rate increases among liquid names PremiumThe FlyLongboard Pharmaceuticals downgraded to Hold from Buy at Truist Longboard Pharmaceuticals downgraded to Neutral from Outperform at Baird M&A News: Lundbeck to Acquire Longboard (NASDAQ:LBPH) for $2.6B PremiumThe FlyLongboard Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald Morning Movers: Longboard Pharmaceuticals surges following deal to be acquired Lundbeck to acquire Longboard Pharmaceuticals for $60.00 per share, or $2.6B